Clinical experience in the treatment of COVID-19 with monoclonal antibodies in solid organ transplant recipients
Description
Solid organ transplant (SOT) recipients are at high risk for complications from coronavirus disease 2019 (COVID-19). SOT recipients mount lower immunological responses to vaccines than general population and are at high risk for breakthrough COVID-19
